Comparison of Forceps, Cryoprobe, and Thoracoscopic Lung Biopsy for the Diagnosis of Interstitial Lung Disease - The CHILL Study.

Cryobioposy Forceps transbronchial lung biopsy Interstitial lung disease Surgical lung biopsy Transbronchial lung cryobiopsy

Journal

Respiration; international review of thoracic diseases
ISSN: 1423-0356
Titre abrégé: Respiration
Pays: Switzerland
ID NLM: 0137356

Informations de publication

Date de publication:
2022
Historique:
received: 15 03 2021
accepted: 13 09 2021
pubmed: 17 11 2021
medline: 6 4 2022
entrez: 16 11 2021
Statut: ppublish

Résumé

Transbronchial lung cryobiopsy (TBLC) has emerged as a less invasive method to obtain a tissue diagnosis in patients with interstitial lung disease (ILD). The diagnostic yield of TBLC compared to surgical lung biopsy (SLB) remains uncertain. The aim of this study was to determine the diagnostic accuracy of forceps transbronchial lung biopsy (TBLB) and TBLC compared to SLB when making the final diagnosis based on multidisciplinary discussion (MDD). Patients enrolled in the study underwent sequential TBLB and TBLC followed immediately by SLB. De-identified cases, with blinding of the biopsy method, were reviewed by a blinded pathologist and then discussed at a multidisciplinary conference. Between August 2013 and October 2017, we enrolled 16 patients. The raw agreement between TBLC and SLB for the MDD final diagnosis was 68.75% with a Cohen's kappa of 0.6 (95% CI 0.39, 0.81). Raw agreement and Cohen's kappa of TBLB versus TBLC and TBLB versus SLB for the MDD final diagnosis were much lower (50%, 0.21 [95% CI 0, 0.42] and 18.75%, 0.08 [95% CI -0.03, 0.19], respectively). TBLC was associated with mild bleeding (grade 1 bleeding requiring suction to clear) in 56.2% of patients. In patients with ILD who have an uncertain type based on clinical and radiographic data and require tissue sampling to obtain a specific diagnosis, TBLC showed moderate correlation with SLB when making the diagnosis with MDD guidance. TBLB showed poor concordance with both TBLC and SLB MDD diagnoses.

Identifiants

pubmed: 34784603
pii: 000519674
doi: 10.1159/000519674
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

394-400

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Momen M Wahidi (MM)

Division of Pulmonary, Allergy and Critical Care, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Angela Christine Argento (AC)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Northwestern University, Chicago, Illinois, USA.

Kamran Mahmood (K)

Division of Pulmonary, Allergy and Critical Care, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Scott L Shofer (SL)

Division of Pulmonary, Allergy and Critical Care, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Coral Giovacchini (C)

Division of Pulmonary, Allergy and Critical Care, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Aaron Pulsipher (A)

Division of Pulmonary, Allergy and Critical Care, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Matthew Hartwig (M)

Division of Cardiothoracic Surgery, Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.

Betty Tong (B)

Division of Cardiothoracic Surgery, Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.

John M Carney (JM)

Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.

Thomas Colby (T)

Department of Pathology and Laboratory Medicine (Emeritus), Mayo Clinic, Phoenix, Arizona, USA.

Ben Neely (B)

Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.

Xiaofei Wang (X)

Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.

Jane Dematte (J)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Northwestern University, Chicago, Illinois, USA.

Neil Ninan (N)

Pulmonary and Critical Care Medicine, Touro Infirmary, New Orleans, Louisiana, USA.

Sonye Danoff (S)

Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Lake Daniel Morrison (LD)

Division of Pulmonary, Allergy and Critical Care, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Lonny Yarmus (L)

Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH